Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
2011

Immunomodulatory Therapy with Mistletoe Extracts

publication Evidence: moderate

Author Information

Author(s): Tibor Hajtó, Krisztina Fodor, Pál Perjési, Pèter Németh

Primary Institution: University of Pécs, Pécs, Hungary

Hypothesis

The study investigates the immunological efficacy of mistletoe extracts in cancer therapy.

Conclusion

Mistletoe extracts may improve the immune balance in cancer patients, but their clinical application faces significant challenges.

Supporting Evidence

  • Mistletoe extracts have shown potential in improving the quality of life for cancer patients.
  • The immunological effects of mistletoe extracts are linked to their lectin activity.
  • Clinical trials often lack clear immunological concepts and standardized dosing.

Takeaway

Mistletoe extracts can help the immune system fight cancer, but doctors need to use them carefully and understand how they work.

Methodology

The review discusses various studies and clinical trials related to mistletoe extracts and their immunological effects.

Potential Biases

The review highlights potential biases due to the variability in mistletoe extract preparations and their clinical applications.

Limitations

The lack of standardized dosing and immunological evidence in clinical trials limits the effectiveness of mistletoe extracts.

Digital Object Identifier (DOI)

10.1093/ecam/nep191

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication